These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 352139)

  • 1. Gallstone dissolution by chenodeoxycholic acid and phenobarbital.
    Marks JW; Sherman JH; Bonorris GG; Chung A; Coyne MJ; Schoenfield LJ
    Am J Gastroenterol; 1978 Feb; 69(2):160-5. PubMed ID: 352139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
    Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ
    J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of gallstones with chenodeoxycholic acid and phenobarbital.
    Coyne MJ; Bonorris GG; Chung A; Goldstein LI; Lahana D; Schoenfield LJ
    N Engl J Med; 1975 Mar; 292(12):604-7. PubMed ID: 1089875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of chenodiol on biliary lipids and their association with gallstone dissolution in the National Cooperative Gallstone Study (NCGS).
    Grundy SM; Lan SP; Lachin J
    J Clin Invest; 1984 Apr; 73(4):1156-66. PubMed ID: 6368591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy.
    Iser JH; Dowling H; Mok HY; Bell GD
    N Engl J Med; 1975 Aug; 293(8):378-83. PubMed ID: 1152936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of ursodeoxycholic acid for dissolution of gallstone fragments: comparison with the combination of ursodeoxycholic acid and chenodeoxycholic acid.
    Sackmann M; Pauletzki J; Aydemir U; Holl J; Sauerbruch T; Hasford J; Paumgartner G
    Hepatology; 1991 Dec; 14(6):1136-41. PubMed ID: 1959863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral dissolution therapy for cholelithiasis: mix and match.
    Phillips RS; Barkin JS
    Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary cholesterol affects chenodeoxycholic acid action on biliary lipids.
    Coyne MJ; Bonorris GG; Chung A; Cove H; Schoenfield LJ
    Gastroenterology; 1977 May; 72(5 Pt 1):927-31. PubMed ID: 849824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of the clinical significance of the treatment of gallstones with chenodeoxycholic acid.
    Johansson G
    Surg Gynecol Obstet; 1984 Aug; 159(2):127-9. PubMed ID: 6463820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Positive effects of chenodeoxycholic acid (CDCA) on the biohumoral clinical aspect of cholesterin calculosis of the gallbladder].
    Corazza GR; Simeone E; Di Giammarco AM; Ciccarelli R; Tenaglia G
    Minerva Med; 1978 Mar; 69(12):758-61. PubMed ID: 643217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incomplete dissolution of calculi. Calcification, cholecystectomy, after treatment of biliary lithiasis with chenodeoxycholic acid].
    Toulet J; Rousselet J; Viteau JM; Duchon Y; Pagniez R; Samain B; Vienne JL
    Gastroenterol Clin Biol; 1983 Dec; 7(12):969-74. PubMed ID: 6662332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dissolution of gallstones by chenodeoxycholic acid].
    Brändli HH; Hefti ML; Blum AL
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1770-3. PubMed ID: 337470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of chenodeoxycholic acid (chenodiol) therapy of cholesterol gallstones.
    Zak RA; Marks JW; Schoenfield LJ
    Semin Liver Dis; 1983 May; 3(2):132-45. PubMed ID: 6408740
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of patients with gallstones with chenodeoxycholic acid (author's transl)].
    Leuschner U; Reber E; Erb W
    Dtsch Med Wochenschr; 1977 Feb; 102(5):156-60. PubMed ID: 832601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The present status of agents for dissolving gallstones.
    Tangedahl T
    Am J Gastroenterol; 1985 Jan; 80(1):64-6. PubMed ID: 3881015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dissolution of gallstones: reality and prospects].
    Dederer IuM
    Klin Med (Mosk); 1980 May; 58(5):16-21. PubMed ID: 6991803
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrence.
    Maton PN; Iser JH; Reuben A; Saxton HM; Murphy GM; Dowling RH
    Medicine (Baltimore); 1982 Mar; 61(2):86-97. PubMed ID: 7062856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light and electron microscopy of human liver before and during chenodeoxycholic acid therapy.
    Hartmann W; Paulini K; Goebell H
    Hepatogastroenterology; 1980 Apr; 27(2):91-8. PubMed ID: 7216131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.